FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1960-1969 May 6, 2004 Number 19 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Muenzer, J. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

ABSTRACT

Background Hurler's syndrome (the most severe form of mucopolysaccharidosis type I) causes progressive deterioration of the central nervous system and death in childhood. Allogeneic bone marrow transplantation before the age of two years halts disease progression and prolongs life, but many children lack a bone marrow donor. We investigated the feasibility of using cord-blood transplants from unrelated donors and a myeloablative preparative regimen that did not involve total-body irradiation in young children with Hurler's syndrome.

Methods Between December 1995 and October 2002, 20 consecutive children with Hurler's syndrome received busulfan, cyclophosphamide, and antithymocyte globulin before receiving cord-blood transplants from unrelated donors. The children were subsequently evaluated for engraftment, adverse effects, and effects on disease symptoms.

Results Cord-blood donors had normal -L-iduronidase activity (mean number of cells, 10.53x10⁷ per kilogram of body weight) and were discordant for up to three of six HLA markers. Neutrophil engraftment occurred a median of 24 days after transplantation. Five patients had grade II or grade III acute graft-versus-host disease; none had extensive chronic graft-versus-host disease. Seventeen of the 20 children were alive a median of 905 days after transplantation, with complete donor chimerism and normal peripheral-blood -L-iduronidase activity (event-free survival rate, 85 percent). Transplantation improved neurocognitive performance and decreased somatic features of Hurler's syndrome.

Conclusions Cord blood from unrelated donors appears to be an excellent source of stem cells for transplantation in patients with Hurler's syndrome. Sustained engraftment can be achieved without total-body irradiation. Cord-blood transplantation favorably altered the natural history of Hurler's syndrome and thus may be important to consider in young children with this form of the disease.

Source Information

From the Pediatric Stem Cell Transplant Program, Duke University Medical Center, Durham, N.C. (S.L.S., P.L.M., P.S., J.A.-T., S.W., J.K.); the Center for Development and Learning (M.L.E.) and the Frank Porter Graham Child Development Center (M.P.), University of North Carolina School of Medicine, Chapel Hill; Emmes Corporation, Rockville, Md. (Y.K.); Jefferson Medical College, Philadelphia (D.A.W.); the Placental Blood Program, New York Blood Center, New York (P.R.); Women's and Children's Hospital, Adelaide, Australia (J.J.H.); and the University of Minnesota School of Medicine, Minneapolis (W.K.).

Address reprint requests to Dr. Staba at Box 3350, Duke University Medical Center, Durham, NC 27710, or at staba001{at}mc.duke.edu.

Full Text of this Article

Related Letters:

Cord-Blood Transplants from Unrelated Donors in Hurler's Syndrome
Fujisaki G., Kami M., Kishi Y., Staba S. L., Kurtzberg J.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:506-507, Jul 29, 2004. Correspondence

This article has been cited by other articles:

• Prasad, V. K., Mendizabal, A., Parikh, S. H., Szabolcs, P., Driscoll, T. A., Page, K., Lakshminarayanan, S., Allison, J., Wood, S., Semmel, D., Escolar, M. L., Martin, P. L., Carter, S., Kurtzberg, J. (2008). Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112: 2979-2989 [Abstract] [Full Text]  
• Congdon, K. L., Voermans, C., Ferguson, E. C., DiMascio, L. N., Uqoezwa, M., Zhao, C., Reya, T. (2008). Activation of Wnt Signaling in Hematopoietic Regeneration. Stem Cells 26: 1202-1210 [Abstract] [Full Text]  
• Bailey, D. B. Jr, Armstrong, F. D., Kemper, A. R., Skinner, D., Warren, S. F. (2008). Supporting Family Adaptation to Presymptomatic and "Untreatable" Conditions in an Era of Expanded Newborn Screening. J Pediatr Psychol 0: jsn032v1-jsn032 [Abstract] [Full Text]  
• Warner, H. R. (2007). 2006 Kent Award Lecture: Is Cell Death and Replacement a Factor in Aging?. J. Gerontol. A Biol. Sci. Med. Sci. 62: 1228-1232 [Abstract] [Full Text]  
• Liao, S M, Goldschmidt, P J, Sugarman, J (2007). Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J. Med. Ethics 33: 643-646 [Abstract] [Full Text]  
• Dusing, S. C, Thorpe, D. E, Poe, M. D, Rosenberg, A. E, Mercer, V. S, Escolar, M. L (2007). Gross Motor Development of Children With Hurler Syndrome After Umbilical Cord Blood Transplantation. ptjournal 87: 1433-1440 [Abstract] [Full Text]  
• Giugliani, R., Harmatz, P., Wraith, J. E. (2007). Management Guidelines for Mucopolysaccharidosis VI. Pediatrics 120: 405-418 [Abstract] [Full Text]  
• Dusing, S. C, Thorpe, D. E, Mercer, V. S, Rosenberg, A. E, Poe, M. D, Escolar, M. L (2007). Temporal and Spatial Gait Characteristics of Children With Hurler Syndrome After Umbilical Cord Blood Transplantation. ptjournal 87: 978-985 [Abstract] [Full Text]  
• Barker, J. N. (2007). Umbilical Cord Blood (UCB) Transplantation: An Alternative to the Use of Unrelated Volunteer Donors?. ASH Education Book 2007: 55-61 [Abstract] [Full Text]  
• Section on Hematology/Oncology and Section on Alle, (2007). Cord Blood Banking for Potential Future Transplantation. Pediatrics 119: 165-170 [Abstract] [Full Text]  
• Goldschmidt-Clermont, P. J., Lam, G. K.W., Dzau, V. J., Dong, C., Kurtzberg, J., Creager, M. A., Losordo, D. W., Wassef, M. (2006). Response to Letter Regarding Article "Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses". Circulation 113: e783-e783 [Full Text]  
• Moise, K. J. Jr (2005). Umbilical Cord Stem Cells. Obstet Gynecol 106: 1393-1407 [Abstract] [Full Text]  
• Warner, H. R. (2005). Developing a Research Agenda in Biogerontology: Basic Mechanisms. Sci Aging Knowl Environ 2005: pe33-pe33 [Abstract] [Full Text]  
• Pan, C., Nelson, M. S., Reyes, M., Koodie, L., Brazil, J. J., Stephenson, E. J., Zhao, R. C., Peters, C., Selleck, S. B., Stringer, S. E., Gupta, P. (2005). Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. Blood 106: 1956-1964 [Abstract] [Full Text]  
• Hopkin, R. (2005). Treatments now available for lysosomal storage diseases. AAP News 26: 10-11 [Full Text]  
• Ecker, J. L., Greene, M. F. (2005). The Case Against Private Umbilical Cord Blood Banking. Obstet Gynecol 105: 1282-1284 [Full Text]  
• Escolar, M. L., Poe, M. D., Provenzale, J. M., Richards, K. C., Allison, J., Wood, S., Wenger, D. A., Pietryga, D., Wall, D., Champagne, M., Morse, R., Krivit, W., Kurtzberg, J. (2005). Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease. NEJM 352: 2069-2081 [Abstract] [Full Text]  
• Ballen, K. K. (2005). New trends in umbilical cord blood transplantation. Blood 105: 3786-3792 [Abstract] [Full Text]  
• Isman, F., Palomaki, G. E., Natowicz, M. R. (2005). Lysosomal Enzymes in Human Peripheral Blood Mononuclear Cells and Granulocytes. Clin. Chem. 51: 646-649 [Full Text]  
• Fujisaki, G., Kami, M., Kishi, Y., Staba, S. L., Kurtzberg, J. (2004). Cord-Blood Transplants from Unrelated Donors in Hurler's Syndrome. NEJM 351: 506-507 [Full Text]